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ABSTRACT
Staphylococcus epidermidis normally is a commensal inhabitant of healthy human skin 
and mucosa, but also a common nosocomial pathogen in immunocompromised patients, 
neonates, and patients with indwelling medical devices. To distinguish the pathogen and 
commensal strain is a big challenge when identifying this agent with its related infection. 
This mini-review aims to summarize recent research in this area with a special emphasis 
on the virulence factor of generating genotypic and phenotypic diversity in S. epidermidis. 
By living between a commensal and pathogen, S. epidermidis needed to establish many 
strategies to face different clinical environments, including the new ecological niche of 
biomaterials. In addition, the growing number of immunocompromised patients increased 
the risk for a very sensitive host. However, further exploration of the relationship between 
virulence factor and in vivo pathogenesis is still needed. According to the virulence factor 
of these bacteria, which are considered as a real pathogen, strict control measures should 
be taken for S. epidermidis infection.
ABSTRAK
Staphylococcus epidermidis merupakan bakteri komensal kulit dan mukosa 
pada manusia, tetapi akhir-akhir ini banyak ditemukan sebagai agen patogen 
infeksi nosokomial terutama pada pasien immunocompromised, neonatus, dan 
pasien dengan peralatan medis invasif. Saat ini, bagaimana membedakan S. 
epidermidis strain patogen dan komensal masih merupakan tantangan besar, baik 
di laboratorium maupun bagi klinisi. Tinjauan ini bertujuan untuk mendiskusikan 
peran faktor virulensi S. epidermidis dalam menyebabkan keragaman genotipik 
dan fenotipik serta keterkaitannya dengan perubahan karakterisitik S. epidermidis, 
sebagai bakteri komensal maupun patogen. Dengan hidup di antara pola komensal 
dan patogen, S. epidermidis perlu menyusun banyak strategi untuk menghadapi 
lingkungan klinis yang beragam, termasuk beradaptasi dengan permukaan 
biomaterial yang merupakan bahan dari peralatan medis invasif. Selain itu, 
meningkatnya jumlah penderita immunocompromised, menyebabkan peningkatan 
kepekaan host terhadap infeksi S. epidermidis.  Namun, penelitian lebih lanjut 
tentang hubungan antara faktor virulensi dan patogenesis infeksi in vivo masih 
diperlukan. Dengan pertimbangan bisa berperan sebagai bakteri patogen, tindakan 
pengendalian yang ketat harus dilakukan untuk infeksi S. epidermidis.
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INTRODUCTION
Staphylococcus epidermidis is a coagulase-
negative Staphylococcus, considered as a part 
of the normal mucosa and skin microflora of 
humans and other mammals.1,2 It is considered 
as a member of the Staphylococci genus, 
which are gram-positive bacteria belonging 
to the family Staphylococcaceae. They are 
clustering, non-motile and non-spore forming 
cocci, facultative anaerobes and produce 
catalase. Currently, there are 35 known species 
of the genus Staphylococcus, from which 15 
species are indigenous to humans, while the 
others are non-human pathogens.2,3 Coagulase-
negative staphylococci (CNS) are grouped 
together as Staphylococcus saprophyticus (S. 
saprophyticus), Staphylococcus lugdunensis 
(S. lugdunensis), Staphylococcus schleiferi 
(S. schleiferi), Staphylococcus haemolyticus 
(S. haemolyticus), Staphylococcus caprae 
(S. caprae) or S. epidermidis based on their 
inability to clot blood plasma. Coagulase-
negative staphylococci are widely distributed 
over the surface of the human body, where 
they constitute the majority of the commensal 
bacterial skin microflora.1
Culture analysis has revealed that 
Staphylococcus spp. are the most abundant 
organisms colonizing moist areas. These moist 
sites include the umbilicus, the axillary vault, 
the inguinal crease (side of the groin), the 
gluteal crease, the sole of the foot, the popliteal 
fossa (behind the knee), nares anterior, 
and the antecubital fossa (inner elbow).1 
Staphylococci occupy an aerobic niche on 
the skin and probably use the urea present in 
sweat as a nitrogen source.3 In spite of being 
a saprophyte and opportunistic bacterium, this 
bacteria is involved in balancing the epithelial 
microflora and serves as a reservoir of 
resistance genes, which might be transferred 
to the closely related but more virulent 
organisms, such as Staphylococcus aureus 
(S. aureus).4 Accordingly, S. epidermidis 
maintains a commonly mutualism relationship 
with its host and serves as a shield, preventing 
colonization of potentially more harmful 
bacteria by producing lantibiotics, which are 
lanthionine-containing antibacterial peptides, 
also known as bacteriocins that may provide 
an added level of protection against certain 
common pathogens. Additionally, acting 
as skin microbiome, this bacteria promote 
the integrity of cutaneous defence through 
elicitation of host immune responses. 4,5 As 
an innocuous commensal microorganism, 
S. epidermidis was for a long time seen as 
an virulent species. However, today this 
bacterium is considered the most frequent 
cause of healthcare associated infections 
(HAIs), namely those related with indwelling 
medical devices. Overall, S. epidermidis is the 
most common species in HAIs, followed by 
S. haemolyticus, S. hominis, and S. capitis.6–8 
it has not been established that adherence 
and biofilm formation are closely linked 
phenotypes for clinical isolates. In this study, 
the initial adhesion to different materials 
(acrylic and glass For example, S. epidermidis 
may be involved in prosthetic joint, vascular 
graft, surgical site, central nervous system 
shunt and cardiac device infections.5,9–11 
In contrast to S. aureus, S. epidermidis 
does not produce many aggressive virulence 
factors, and consequently the infections caused 
are, at least in immunocompetent patients, 
often low-grade and chronic. For severely 
immunocompromised patients, S. epidermidis 
may develop into a life-threatening pathogen 
triggering septicaemia, meningitis, and 
other serious conditions1,12 Staphylococcus 
epidermidis infections mostly are considered 
as being extremely recalcitrant to therapy. 
This is due to high antibiotic resistance rates 
among nosocomial S. epidermidis isolates, 
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but treatment failure is also associated with 
the ability of S. epidermidis to form biofilms 
on inert surfaces of medical devices from 
where these sticky, multilayered aggregates 
of bacteria are hard, if at all possible, to 
completely remove.13,14 
Additionally, the increasing use of 
biomaterials in modern medicine has improved 
the quality of life of many patients. However, 
as a drawback, the occurrence of biomaterial-
associated infections (BAI) is increasing 
and now becoming a serious health threat to 
patients, as well as a financial burden to the 
society. S. epidermidis, generally regarded as 
an opportunist pathogen, is now recognised as 
a real “new” pathogen, since it is the major 
etiologic agent of BAI.10,11,15 Biomaterial-
associated infections is generally related to 
microbial biofilm formation, defined as a 
microbial community encased in a matrix 
of self-produced extracellular polymeric 
substances (slime). Slime affects antimicrobial 
resistance as well as the effectiveness of 
the host immune system14,16. Currently, no 
effective non-invasive technique exists to 
prevent or destroy biofilms associated with 
BAI. Systemic antibiotics predominantly 
attack a biofilm infection through the 
outermost layers of the biofilm, which are 
usually ineffective as bacteria continue to 
grow from the inner layers combined with 
an increased production of extracellular 
polymeric substances. This virulence 
constitutes the main reason why biomaterial 
implants related to an infection nearly always 
have to be removed.17 In addition, the use of 
antibiotics and disinfectants in hospitals puts 
a high selective pressure on bacteria to select 
for resistant and well-adapted variants.18,19 
However, this unique pattern does not yet 
explain why just S. epidermidis and not any 
other bacteria, was able to conquer and occupy 
this novel ecological niche.
Notably, it has been shown that the 
genomic structure of S. epidermidis represents 
an amazingly versatile microorganism living 
in a grey area between commensalism 
and pathogenicity. S. epidermidis employs 
sophisticated regulatory networks to 
quickly adapt its metabolism to changing 
external conditions, to communicate with 
its neighbours in the same ecological niche, 
or to escape the host’s immune response.8,20 
Genomic analyses demonstrated the presence 
of numerous mobile genetic elements in S. 
epidermidis genomes, including methicillin 
resistance-mediating SCCmec elements and 
insertion sequences (IS). IS elements seem to 
be important driving forces that keep the S. 
epidermidis genome extremely flexible and 
trigger heterogeneous gene expression.21It is 
suggested that well-adaptability properties 
both on the regulatory and genetic level might 
have contributed to the evolutionary success 
of S. epidermidis as a nosocomial pathogen.8 
Meanwhile, due to the ubiquitous prevalence 
of S. epidermidis as a commensal bacterium, 
clinicians often face the challenge to decide 
whether an isolate represents the causative 
agent of an infection or an unspecific culture 
contamination. Nowadays, our understanding 
of how S. epidermidis becomes a commensal 
or pathogen is far from complete and many 
questions still remain. This review addresses 
the questions concerning how the recent 
mechanism of commensal and infectious 
lifestyles of S. epidermidis takes place, 
which more focusing on  literature about 
virulence properties of S. epidermidis i.e 
biofilm formation, icaADBC presence and the 
mechanism of regulating gene expression, the 
role of small colony variant and methicillin 
resistance gene, as well as its genomic 
flexibility.
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DISCUSSION
Biofilm formation, major pathomechanism 
of HAIs infection
One of the main virulence characteristics 
of S. epidermidis is related with their adhesion 
to substratum surfaces and subsequent biofilm 
formation.5,10 A biofilm is a population of cells 
growing on a surface and enclosed in a self-
produced matrix of extracellular polymeric 
substance (EPS). Biofilms are notoriously 
difficult to eradicate and are a source of 
many recalcitrant infections.14 Bacterial 
biofilm formation comprises a number of 
physical, biological, and chemical processes. 
The relative contribution of each process 
changes throughout biofilm development 
and depends on prevailing environmental 
and hydrodynamic conditions.22 In general, 
biofilm formation can be described in five 
phases 5,23,24  as shown in FIGURE 1. 
FIGURE 1. The phases of biofilm formation in S. epidermidis. Graphs 
were modified from Vuong et al., Nuryastuti, and Bos et 
al.5,23,24
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Substratum surfaces will first become 
covered with a conditioning film consisting 
of proteins and glycoproteins, such as 
fibronectin, vitronectin, fibrinogen, albumin, 
and immuno-globulins, many of which serve 
as binding ligands to receptors on colonizing 
bacteria, although adhesion can also occur to 
bare substratum surfaces. Biofilm formation 
continues with the transport of bacteria to 
the substratum-liquid interface, which is 
governed by a combination of transport 
mechanisms, including Brownian motion, 
gravity, diffusion, convection, or the intrinsic 
motility of a microorganism.23,24 Subsequently, 
in the second phase, microbial adhesion may 
occur which is initially of a reversible nature. 
Factors involved in the initial adhesion to 
a substratum surface include non-specific 
interactions originating from both the 
bacterial cell and substratum surfaces. These 
non-specific interactions are governed by 
physicochemical properties such as surface 
charge, hydrophobicity, and chemical structure 
of both the bacteria and substratum surface. In 
the third phase, reversible adhesion of bacteria 
changes to irreversible, amongst others due to 
protein-protein interactions and the production 
of EPS. The fourth phase in biofilm formation 
is surface colonization. Adhering bacteria 
grow and divide, forming microcolonies that 
are considered to be the basic organizational 
units of a biofilm. Entrapment of other 
planktonic bacteria in the EPS also occurs, 
resulting in a multi-layered and mature 
biofilm.5,23 The last step is detachment of 
individual bacteria or aggregates, which 
allows bacteria to disseminate into other 
areas for further surface colonization. In the 
clinical setting, this last step generally leads 
to severe systemic infections.5 As a pivotal 
structural component of microbial biofilms, 
EPS has received much attention. In general, 
EPS consists of polysaccharides, eDNA 
and proteins in a hydrated environment.26,27 
Recently eDNA was found to be a major 
structural component of bacterial EPS where 
it plays a role in bacterium-surface and 
bacterium-bacterium interactions. The EPS 
produced by S. epidermidis consists mostly of 
polysaccharide intercellular adhesin (PIA).26 
icaADBC and the mechanism of regulation 
of expression
Production of PIA, a key virulence factor 
of S. epidermidis, is subject to on-off switching, 
resulting in phenotypic variability (phase 
variants).11,15,28 Polysaccharide intercellular 
adhesion production is stimulated through the 
action of membrane bound sensory proteins 
within the bacterial cell wall. Polysaccharide 
intercellular adhesion synthesis is catalyzed 
by proteins encoded within the ica operon, 
a gene cluster consisting of icaADBC. The 
icaA gene product is a transmembrane 
protein with homology to N-acetyl-gluco-
saminyltransferases. The functions of icaB 
and icaC are less well defined. However, icaB 
is likely to be secreted while icaC is predicted 
to be an integral membrane protein. icaD 
might act as a link between icaA and icaC and 
represent a novel enzyme combination. When 
icaA is co-expressed with icaD, the transferase 
activity increases 20 fold.11,29
Extracellular polymeric substance  pro-
duction is vital, but metabolically expensive 
for S. epidermidis and therefore well-
regulated (FIGURE 2). Regulation of ica-
expression and biofilm formation is negatively 
controlled by the ica operon regulator, IcaR 
and teiocoplanin-associated locus regulator, 
TcaR. It is also influenced by environmental 
conditions that are potentially toxic for the 
bacterial cell. The exposure of S. epidermidis 
to a high osmolarity, high temperature, 
detergents, urea, ethanol, the presence of 
sub-MIC (Minimal Inhibitory Concentration) 
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concentrations of certain antibiotics, glucose, 
iron limitation and oxidative stress have all 
been shown to elevate ica-expression and 
biofilm formation.30–32 Moreover, the global 
stress response factor σB, positively regulates 
ica-expression by negatively regulating icaR 
expression, while staphylococcal accessory 
regulator A (sarA) and regulators of sigmaB 
(rsbU) act similarly.33 In addition, the LuxS 
system involved in quorum sensing in S. 
epidermidis, recently emerged as another 
negative regulator of biofilm formation.11
FIGURE 2. The schematic overview of regulatory network controlling expression of icaADBC 
in S. epidermidis. Graphs were modified from Nuryastuti.23
The genetic and molecular basis of biofilm 
formation in S. epidermidis is multi-faceted. It 
has been reviewed that there are two distinct 
mechanisms of biofilm development; through 
an ica-dependent and an ica-independent 
mechanism of biofilm development.11 Biofilm 
production by ica operon-encoded enzymes 
is currently the best-understood biofilm 
mechanism in staphylococci,11 which is 
regulated by several regulatory genes such 
as icaR, ơB, rsbU and sarA, including the 
reversible integration of the IS256 into those 
genes.28,34 Additionally, a surface protein 
homologous to biofilm-associated protein 
(Bap), accumulation-associated protein (Aap), 
and considerable amounts of extracellular 
teichoic acids (ECTA)8 have been identified 
to be involved in ica-independent biofilm 
formation in some S. epidermidis, which is 
also under control of the sarA regulatory 
gene.11
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Recent studies imply that the multicellular 
organization of bacteria in a biofilm is a 
crucial mechanism in resisting unfavorable 
conditions.35 Heterogeneous gene expression 
is typically observed in clinical S. epidermidis 
strains, and it is assumed that this ability is 
an advantage for adaptation of staphylococci 
to changing environmental conditions.8 Phase 
variation involves both regulatory pathways, 
e.g. in response to environmental signals, as 
well as genetic variations, by local genomic 
re-arrangements, altered activity of regulatory 
proteins or modulation of transcription or 
translation of the appropriate gene through 
strand slip mechanisms.8,11,23 
Polysaccharide intercellular adhesin 
is the most important component of the 
staphylococcal slime and its production is 
catalyzed by proteins encoded within the 
icaADBC operon. Different S. epidermidis 
strains vary widely in the degree of PIA 
or slime, and biofilm they produce.5,36 The 
importance of the ica operon has been 
confirmed in numerous epidemiological 
studies, which found a higher prevalence of 
the ica genes in clinical than in control skin 
isolates.37,38 Clinical strains of S. epidermidis 
obtained from urinary tract infection,39 as well 
as from paediatric cancer patients receiving 
chemotherapy are reported to be related with 
ica-presence.25
Epidemiological studies have shown 
that the icaADBC operon is a typical 
feature of nosocomial S. epidermidis strains 
obtained from device-associated infections. 
10,33 It is shown that icaADBC operon is 
mostly prevalent in strains associated with 
intravascular catheter-associated bacteraemia 
and septicaemia.10,39 A study of the occurrence 
of ica operon among S. epidermidis isolates 
obtained from various origins has indicated 
that the genetic information for biofilm 
formation is rarely found in isolates obtained 
outside of hospital settings.18 Interestingly, 
many of these studies found that invasive S. 
epidermidis strains significantly more often 
carried icaADBC than colonizing commensal 
S. epidermidis strains. Therefore, icaADBC-
negative S. epidermidis strains were regarded 
as non-virulent and it was proposed to use 
icaADBC as a genetic marker to distinguish 
invasive and contaminating S. epidermidis in 
blood cultures.37,38 
Phenotypic and genotypic instability of 
biofilm-forming ability
Phenotypic variation in ica-presence 
is commonly observed in S. epidermidis. 
8,28,40 Ziebuhr and coworkers identified an 
insertional element (IS256) that was capable 
of inserting itself into the ica-locus resulting 
in ica-negative phenotypes.8 This disruption 
was shown to be reversible as precise excision 
from the ica-locus which observed at low 
incidence resulting in ica-positive phenotypes.
We and others have shown that a 
significant proportion (42-85%) of clinical 
isolates are ica-negative during culturing in the 
laboratory.28,40 In contrast to studies showing a 
reversible switching (phenotypic switching) 
between ica-positive and ica-negative 
phenotypes, the ica-locus was permanently 
lost in these strains. The absence of IS256 
and phenotypic variation in these clinical 
S. epidermidis isolates and the inability to 
switch back to ica-positive suggested a new 
mechanism of switching in terms of biofilm 
formation involving genetic instability.28
We showed that the presence of the 
ica-locus in clinical isolates represents 
a disadvantage for growth in laboratory 
conditions. In line with this, it was recently 
suggested that the presence of the icaADBC 
operon represents a disadvantage when S. 
epidermidis colonizes the skin.3,28
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Strains that have a high level of PIA 
production have a significant growth 
disadvantage under commensal conditions 
and are therefore outcompeted by strains 
with more moderate or absent PIA 
production. Whereas PIA production enables 
staphylococci to survive and grow under 
hostile, infection related conditions (biofilms), 
during commensal colonization (as well as 
during planktonic growth), PIA production 
can be considered a burden that can easily be 
subsided. It is important to conclude that the 
ability to express different slime-producing 
phenotypes could provide staphylococci with 
a greater degree of flexibility for colonizing a 
range of different environments.33 Too much 
or no PIA production is only favourable 
under specific conditions while the ability to 
regulate PIA production allows the organism 
to adapt to all conditions, both commensal 
and infectious.23
Other studies have found, in S. 
epidermidis, IS256 detection is attributed 
to the epidemic biofilm-forming clonal 
lineages, and the element has been shown 
to trigger heterogeneous biofilm expression 
by reversible transposition into biofilm-
associated genes and regulators.21,41
Thus, IS256 was shown to cause phase 
variation of icaADBC operon expression by 
alternating insertion in and precise excision 
from the PIA synthesis-mediating gene 
locus.20 While switch-off of PIA production 
through IS256 insertions occurs with a 
frequency of approximately 10-6 per cell and 
generation, restoration of PIA-dependent 
biofilm formation by precise IS256 excision 
was found to be an extremely rare event (10−11 
per cell and generation).42 
The role of small colony variant (SCV)
Small colony variants are naturally 
occurring subpopulations of bacteria 
demonstrating distinctive phenotypic 
characteristics and pathogenic traits. 
Phenotypically, SCVs have a slow growth 
rate, atypical colony morphology associated 
with the formation of pinpoint or ‘fried 
egg’ colonies and unusual biochemical 
features. It was most extensively studied for 
staphylococci, especially for S. aureus as well 
as S. epidermidis.43 SCVs were recorded as 
being <1 mm in size (less than 1/10 of the 
normal cell size), with reduced pigmentation 
and haemolytic activity as described in 
literature.43,44 The tiny size of SCVs on solid 
agar is often due to auxotrophy for haemin 
and/or menadione, two compounds involved 
in the biosynthesis of electron transport chain 
components, which is associated with defects 
in electron transport and, consequently, altered 
membrane potential. The abnormal membrane 
potential, in turn, may confer on these variants 
innate resistance to aminoglycosides, since 
the ability of these antibiotics to gain access 
to intracellular target sites depends on the 
proton motive force. More importantly, some 
reports have linked bacterial SCVs to several 
recurring infections that are intractable to 
conventional treatment antibiotic regimes.44–46
Small colony variants  have been 
associated with long-lasting, chronic, and 
recurrent infections, and it was suggested 
that this property was linked to the ability 
of SCVs to survive intracellularly, thereby 
being protected from the host immune system 
and the action of antibiotics.  Both biofilm 
formation and the SCV phenotype may 
contribute to the recurrence and persistence of 
staphylococcal infections; bacteria are either 
embedded in large, adherent biofilms on the 
surfaces of implanted foreign bodies or may 
persist intracellularly in phagocytes, such as 
epithelial or endothelial cells, and thus evade 
the host immune system.44,45  Additionally, 
it was proved that in vitro experiment using 
menadione auxotrophs of S. aureus  and 
haemin auxotrophs of S. epidermidis 46 
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resulted in the upregulation of  alternative 
sigma factor B, which plays a central role in 
the augmentation of icaADBC expression and 
PIA production.43,47  
Methicillin resistance gene
In addition to biofilm formation, 
nosocomial S. epidermidis isolates are 
characterized by their pronounced resistance 
against commonly used antibiotics including 
methicillin. Methicillin resistance is, similar 
with S. aureus, mediated by the mecA gene 
encoding a penicillin binding protein with 
reduced affinity to β-lactam antibiotics.48 
However, in contrast to methicillin-resistant S. 
aureus (MRSA), attention paid to methicillin 
resistant S. epidermidis (MRSE) in hospital 
settings is not adequate enough, meaning they 
are not dealt with by using intense hygienic 
measures as those for MRSA. As a result, 
methicillin resistance rates among nosocomial 
S. epidermidis isolates and other CoNS are 
extremely high and regularly exceed those of 
MRSA.48–50 It has been reported approximately 
80% of S. epidermidis isolates from device-
associated infections are considered as 
MRSE, and also found to be multiresistant; 
whereas commensal strains obtained from the 
community are mostly methicillin-sensitive S. 
epidermidis.10
The mecA gene and its regulators are 
located on large DNA elements that are 
termed staphylococcal cassette chromosome 
mec (SCCmec). In addition to the methicillin 
resistance determinant, SCCmec carry a 
set of recombinases and a wide variety of 
mobile DNA elements such as transposons, 
insertion sequences or integrated plasmids.1,15 
To date, five major SCCmec types have been 
identified, all of them can be distributed over 
the S. epidermidis genome. Interestingly, 
SCCmec have been shown to be transferable 
among staphylococcal species. These genes 
are now regarded as mobile elements in 
which extensive recombination and gene 
shuffling takes place.15,51 Obviously, they 
do not only serve as shuttles for the transfer 
of methicillin resistance but can also carry 
other staphylococcal genes. MRSE is 
often associated with additional antibiotic 
resistance, such as erythromycin (encoded 
by erm genes), ciprofloxacin, clindamycin, 
aminoglycosides (encoded in aacA/aphD 
gene) or trimethoprim-sulfamethoxazole.15 
The recent findings of genomic research 
strongly suggest that S. epidermidis and other 
coagulase-negative staphylococci represent 
the gene pool for the ongoing generation of 
novel SCC types from which methicillin 
resistance in S. aureus might originate.1,12 
Accordingly, it would be meaningful and 
reasonable to control MRSE and MR-CoNS 
by appropriate hygiene measures in a similar 
manner for MRSA, in order to lower MRSA 
burden in medical facilities, due to their role 
as reservoirs for the spread of resistance genes 
within microbial communities. 
Genomic flexibility
It was demonstrated that clonal 
diversification in S. epidermidis is mainly 
based on genetic recombination, which is 
in contrast to S. aureus, a species known to 
evolve preferentially by point mutations.21,41
Multilocus sequence typing (MLST) 
analysis of a representative collection of 
clinical S. epidermidis isolates revealed a high 
degree of genetic diversity within the species, 
but the most widespread clone was ST2 or 
ST27 (sequence types). Especially, clonal 
complex ST2 isolates were found to be highly 
flexible with respect to methicillin resistance 
and prone to take up these mobile genetic 
elements. 21 Possibly, the successful spread of 
ST2 may be due to the fact that all ST2 isolates 
contain IS256 insertion sequences and ica 
genes, two factors that may have determinants 
to enhance transmissibility, persistence, or 
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invasiveness in S. epidermidis. In addition, 
most ST2 isolates show in vitro capacity to 
form biofilms.15,21
Instability of genetic material is often 
an indication of mobility, and in this respect 
it is also conceivable that the ica operon 
represents mobile DNA that has been lost 
in the commensal strain. S. epidermidis 
isolates ST 2(ST27) represent an ideal genetic 
background for biofilm and resistance genes, 
resulting in well-adapted strains which are 
then selected in the hospital environment 
and causes device-related infection and 
bacteraemia. The presence of multiple 
copies of IS256 in the ST27 genome might 
support this adaptation process by an ongoing 
generation of novel phenotypic and genotypic 
variants. Therefore, the combination of 
biofilm formation, antibiotic resistance, and 
genetic flexibility may explain why ST2 has 
become the dominant clonal variant within 
medical facilities.8,41
Clinical manifestation of related infection
Staphylococcus epidermidis and other 
CoNS have for a long time been dismissed as 
culture contaminations which is mainly due 
to the fact that CoNS are primarily ubiquitous 
commensals of the human skin and mucosa. 
It is still a great challenge for the clinical 
microbiology laboratory to distinguish 
infecting strains from contaminants. In 
suspected S. epidermidis infections, where the 
pathogen is also a skin commensal that could 
contaminate skin swab or blood specimen if 
aseptic techniques are not followed, the same 
indistinguishable microorganism must be 
cultured from at least two separate specimens 
in order to differentiate a relevant infection 
from skin contamination.52 In contrast, for 
virulent species such as S. aureus or gram 
negative bacteria, a single positive clinical 
specimen may be sufficient to determine the 
presence of a recent infection.53,54 However, 
some groups of the population are prone to 
be infected with this microorganism. These 
higher risk groups include preterm neonates, 
immunocompromised individuals and patients 
with indwelling medical devices.1,5,10 
The most important clinical manifestation 
associated with CoNS, particularly S. 
epidermidis is biomaterial-associated 
infections (BAI), which include a unique, 
complex constellation of many factors that 
have to be considered for their successful 
management.33 The increasing use of foreign 
materials in almost all fields of modern 
medicine is associated with a risk of bacterial 
infection.10 Morbidity and mortality of 
biomaterial-associated infections may vary 
according to the underlying patient condition, 
the microbial strain(s) that are implicated, and 
the type of device. Biomaterial-associated 
infections contribute significantly to the 
increasing problem of nosocomial infections. 
While a variety of microbial strains have 
been involved as causative organisms in 
biomaterial-associated infections, staphylo-
cocci, particularly S. epidermidis, account 
for the majority of infections related to 
both temporarily inserted and permanently 
implanted biomaterials.5,10
The presence of a biomaterial 
significantly compromises the host’s ability to 
cope with infectious microorganisms. These 
microorganisms can reach a biomaterial 
implant in several ways and at different times 
post-implantation. Airborne microorganisms, 
inevitably present in the operating theater, can 
reach a biomaterial implant surface as early as 
before the implantation. Also during insertion 
of a biomaterial implant, microorganisms 
from the commensal microflora of the skin 
can contaminate a biomaterial implant. Peri-
operative contamination is believed to be the 
most common cause of biomaterial associated 
infection.10,18,33  
Bacteria that adhere to implanted medical 
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devices or damaged tissue can encase 
themselves in a hydrated matrix of extra 
cellular polymeric substances, a slimy layer, 
and start growing into a biofilm. Bacteria 
organized in biofilms are at least 10-1000 
times more resistant to antibiotics 14,16 and can 
cope much better with unfavorable external 
conditions as the host immune system than their 
planktonic counterparts. The biofilm mode of 
growth represents a benefit for staphylococcal 
strains enabling them to colonize inert 
surfaces of medical devices.8 Antibiotic 
resistance of bacteria in the biofilm mode 
of growth contributes to the chronic nature 
of these infections, which are notoriously 
difficult to resolve. The mechanisms of 
bacterial resistance in biofilms are different 
from the now familiar plasmids, transposons, 
and mutations that convey innate resistance 
to individual bacterial cells. In biofilms, 
resistance seems to depend on multicellular 
strategies resulting in an impaired penetration 
of antibiotics to the target organisms and a 
decreased immune response.14,55
Biomaterial-associated infections 
comprise local (e.g., exit site) and systemic 
infections. Originating from bacteremia 
or other systemic spread of causative 
organisms and depending on the nature and 
localization of the biomaterial inserted, sepsis, 
endocarditis, meningitis, joint sepsis, vertebral 
abscesses, and other local manifestations due 
to metastatic seeding may result.1,19 These 
comprise infections commonly associated 
with prosthetic vascular grafts, prosthetic heart 
valves, cardiac devices, and coronary stents. 
Moreover, local inflammation signs include 
erythema, warmth, swelling, tenderness, and 
purulent drainage, which characterize exit-
site infections. 
It has been shown that S. epidermidis was 
the most frequent agents of central venous 
catheter (CVC) and umbilical catheter-
associated BSIs (Blood Stream Infection) in 
neonatal ICUs.5,25the coagulase-negative staphylococci (CoNS 
Besides BSIs, the CoNS group may cause 
further invasive infections in preterm infants, 
such as infective endocarditis, meningitis, 
and necrotizing fasciitis.5,12 Additionally, S. 
epidermidis is also considered as the main cause 
of septicemia in febrile patients who suffer 
from chemotherapy-induced neutropenia, 
which is accounting for approximately 20 to 
40% of cases.1,25
CONCLUSION
So far it is still a great challenge for 
clinician to distinguish S. epidermidis strains 
that may cause infection from those that 
live on the skin. However, the virulence 
properties identified in this paper, such as 
the presence of biofilm formation phenotype 
including icaADBC operon, IS256, mecA, 
SCV properties, together with patient 
characteristics, might be used to consider 
the pathogenesis of infection caused by S. 
epidermidis. Nevertheless, up to date, the 
clues to distinguish between infectious and 
commensal strains of S. epidermidis are not 
clear yet. It is well understood the adhesion to 
host tissue is considered crucial during both 
these lifestyles. 
By living on the verge of commensalism and 
pathogenicity, S. epidermidis has elaborated 
many strategies to overcome different clinical 
environments, including the new ecological 
niche of biomaterials. In addition, the growing 
number of immunocompromised patients 
increases the risk for a very sensitive host. 
The formation of biofilms, the acquisition of 
resistance characteristics and the enormous 
flexibility of the genome of staphylococci 
are characteristics that help their survival 
in specific environments and are the main 
reasons why staphylococci have become the 
most successful pathogens in clinical setting. 
With respect to their possible role as true 
pathogens, S. epidermidis infection should be 
J Med Sci, Volume 50, No. 1, 2018 January: 113-127
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taken more seriously with adequate prevention 
applications for future infection control and 
hygiene measures.
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